Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
156
NCT01011322
A Study to Investigate the Efficacy of LT-02 in Patients With Mesalazine Refractory Ulcerative Colitis
Phase: Phase 2
Role: Lead Sponsor
Start: Dec 31, 2009
Completion: Feb 29, 2012